Kiniksa Pharmaceuticals Ltd reports results for the quarter ended in September - Earnings Summary

Kiniksa Pharmaceuticals International

28/02/2024 14:50

* Kiniksa Pharmaceuticals Ltd  KNSA.OQ  reported a quarterly
adjusted loss of 20 cents​​ per share for the quarter ended in
September, lower than the same quarter last year, when the
company reported EPS of $3.18.  The mean expectation of
four analysts for the quarter was for a loss of 17 cents per
share. Wall Street expected results to range from -22 cents
to -11 cents per share.
    * Revenue fell 32.4% to $67.05 million from a year ago;
analysts
expected $64.45 million. 
    * Kiniksa Pharmaceuticals Ltd's reported EPS for the quarter
was a
loss of 20 cents​.
    * The company reported a quarterly loss of $13.86 million.
    * Kiniksa Pharmaceuticals Ltd shares had risen by 19.1% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kiniksa
Pharmaceuticals Ltd is $28.00 
This summary was machine generated from LSEG data February 28 at
02:49 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.17          -0.20          Missed
 Jun. 30 2023      -0.17          0.21           Beat
 Mar. 31 2023      -0.21          -0.18          Beat
 Dec. 31 2022      -0.23          0.06           Beat